Publication | Closed Access

Gemcitabine-oxaliplatin plus rituximab (R-GemOx) as first-line treatment in elderly patients with diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 trial

Hematological MalignancyLymphoid NeoplasiaOncologyElderly PatientsFirst-line TreatmentCancer TreatmentMedicineRadiation Oncology